Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

52.36
Delayed Data
As of 3:59pm ET
 -0.48 / -0.91%
Today’s Change
45.31
Today|||52-Week Range
75.36
-0.78%
Year-to-Date
7 Negative Assets in Gurus' Portfolios
Sep 15 / GuruFocus News - Paid Partner Content
Bristol-Myers' Opdivo Study Meets Early Success, Stock Up
Sep 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close52.84
Today’s open52.87
Day’s range51.67 - 52.87
Volume1,079,105
Average volume (3 months)1,106,469
Market cap$7.6B
Dividend yield--
Data as of 3:59pm ET, 09/21/2017

Growth & Valuation

Earnings growth (last year)-7.53%
Earnings growth (this year)-67.64%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+24.15%
P/E ratioNM
Price/Sales17.76
Price/Book11.85

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc-0.32-0.63%
ALNYAlnylam Pharmaceutic...-0.92-0.81%
TSROTESARO Inc-2.95-2.43%
IONSIonis Pharmaceutical...-2.05-3.80%
Data as of 4:00pm ET, 09/21/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$418.1M
Annual profit (last year)-$140.1M
Net profit margin-33.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts